종양학 분야 AI 시장(2026-2030년)

The global ai in oncology market is forecasted to grow by USD 9455.4 mn during 2025-2030, accelerating at a CAGR of 28.1% during the forecast period. The report on the global ai in oncology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by proliferation of large and complex oncological datasets, imperative for personalized medicine and improved therapeutic outcomes, increasing pressure for operational efficiency and cost containment in healthcare.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global ai in oncology market is segmented as below:

By Component

• Software solutions
• Services

By Type

• Breast cancer
• Lung cancer
• Kidney cancer
• Others

By Application

• Diagnosis
• Drug discovery and development
• Treatment planning
• Prognosis prediction

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
• South America
  • Brazil
  • Argentina
  • Chile
• Middle East and Africa
  • UAE
  • South Africa
  • Turkey
• Rest of World (ROW)

This study identifies the convergence of artificial intelligence and multi-omics data integration as one of the prime reasons driving the global ai in oncology market growth during the next few years. Also, acceleration of drug discovery and development through ai platforms and enhanced diagnostic and prognostic capabilities with ai in radiomics and digital pathology will lead to sizable demand in the market.

The report on the global ai in oncology market covers the following areas:

• Global ai in oncology market sizing
• Global ai in oncology market forecast
• Global ai in oncology market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global ai in oncology market vendors that include Amazon Web Services Inc., Caris Life Sciences, ConcertAI Inc., F. Hoffmann La Roche Ltd., Flatiron Health, GE HealthCare Technologies, Google LLC, Guardant Health Inc., Illumina Inc., Insilico Medicine, Koninklijke Philips NV, Merative L.P., Microsoft Corp., NVIDIA Corp., Owkin Inc., Paige AI Inc., PathAI Inc., Qure.ai Technologies Pvt. Ltd., Siemens Healthineers AG, Tempus AI Inc.. Also, the global ai in oncology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Component
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global AI In Oncology Market 2020 - 2024
  • Historic Market Size - Data Table on Global AI In Oncology Market 2020 - 2024 ($ million)
• 5.2 Component segment analysis 2020 - 2024
  • Historic Market Size - Component Segment 2020 - 2024 ($ million)
• 5.3 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.4 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of geopolitical conflicts on global AI in oncology market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Component

• 8.1 Market segments
• 8.2 Comparison by Component
• 8.3 Software solutions - Market size and forecast 2025-2030
• 8.4 Services - Market size and forecast 2025-2030
• 8.5 Market opportunity by Component
  • Market opportunity by Component ($ million)

9 Market Segmentation by Type

• 9.1 Market segments
• 9.2 Comparison by Type
• 9.3 Breast cancer - Market size and forecast 2025-2030
• 9.4 Lung cancer - Market size and forecast 2025-2030
• 9.5 Kidney cancer - Market size and forecast 2025-2030
• 9.6 Others - Market size and forecast 2025-2030
• 9.7 Market opportunity by Type
  • Market opportunity by Type ($ million)

10 Market Segmentation by Application

• 10.1 Market segments
• 10.2 Comparison by Application
• 10.3 Diagnosis - Market size and forecast 2025-2030
• 10.4 Drug discovery and development - Market size and forecast 2025-2030
• 10.5 Treatment planning - Market size and forecast 2025-2030
• 10.6 Prognosis prediction - Market size and forecast 2025-2030
• 10.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 APAC - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Australia - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 South America - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Argentina - Market size and forecast 2025-2030
  • 12.6.3 Chile - Market size and forecast 2025-2030
• 12.7 Middle East and Africa - Market size and forecast 2025-2030
  • 12.7.1 Saudi Arabia - Market size and forecast 2025-2030
  • 12.7.2 UAE - Market size and forecast 2025-2030
  • 12.7.3 South Africa - Market size and forecast 2025-2030
  • 12.7.4 Israel - Market size and forecast 2025-2030
  • 12.7.5 Turkey - Market size and forecast 2025-2030
• 12.8 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Proliferation of large and complex oncological datasets
  • Imperative for personalized medicine and improved therapeutic outcomes
  • Increasing pressure for operational efficiency and cost containment in healthcare
• 13.2 Market challenges
  • Complex regulatory frameworks
  • High capital expenditure and integration costs
  • Shortage of skilled interdisciplinary labor
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Convergence of artificial intelligence and multi-omics data integration
  • Acceleration of drug discovery and development through AI platforms
  • Enhanced diagnostic and prognostic capabilities with AI in radiomics and digital pathology

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Amazon Web Services Inc.
  • Amazon Web Services Inc. - Overview
  • Amazon Web Services Inc. - Product / Service
  • Amazon Web Services Inc. - Key offerings
  • SWOT
• 15.5 Caris Life Sciences
  • Caris Life Sciences - Overview
  • Caris Life Sciences - Product / Service
  • Caris Life Sciences - Key offerings
  • SWOT
• 15.6 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.7 Flatiron Health
  • Flatiron Health - Overview
  • Flatiron Health - Product / Service
  • Flatiron Health - Key offerings
  • SWOT
• 15.8 GE HealthCare Technologies
  • GE HealthCare Technologies - Overview
  • GE HealthCare Technologies - Business segments
  • GE HealthCare Technologies - Key news
  • GE HealthCare Technologies - Key offerings
  • GE HealthCare Technologies - Segment focus
  • SWOT
• 15.9 Google LLC
  • Google LLC - Overview
  • Google LLC - Product / Service
  • Google LLC - Key offerings
  • SWOT
• 15.10 Guardant Health Inc.
  • Guardant Health Inc. - Overview
  • Guardant Health Inc. - Product / Service
  • Guardant Health Inc. - Key offerings
  • SWOT
• 15.11 Illumina Inc.
  • Illumina Inc. - Overview
  • Illumina Inc. - Business segments
  • Illumina Inc. - Key news
  • Illumina Inc. - Key offerings
  • Illumina Inc. - Segment focus
  • SWOT
• 15.12 Koninklijke Philips NV
  • Koninklijke Philips NV - Overview
  • Koninklijke Philips NV - Business segments
  • Koninklijke Philips NV - Key news
  • Koninklijke Philips NV - Key offerings
  • Koninklijke Philips NV - Segment focus
  • SWOT
• 15.13 Merative L.P.
  • Merative L.P. - Overview
  • Merative L.P. - Product / Service
  • Merative L.P. - Key offerings
  • SWOT
• 15.14 Microsoft Corp.
  • Microsoft Corp. - Overview
  • Microsoft Corp. - Business segments
  • Microsoft Corp. - Key news
  • Microsoft Corp. - Key offerings
  • Microsoft Corp. - Segment focus
  • SWOT
• 15.15 NVIDIA Corp.
  • NVIDIA Corp. - Overview
  • NVIDIA Corp. - Business segments
  • NVIDIA Corp. - Key news
  • NVIDIA Corp. - Key offerings
  • NVIDIA Corp. - Segment focus
  • SWOT
• 15.16 PathAI Inc.
  • PathAI Inc. - Overview
  • PathAI Inc. - Product / Service
  • PathAI Inc. - Key offerings
  • SWOT
• 15.17 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 15.18 Tempus AI Inc.
  • Tempus AI Inc. - Overview
  • Tempus AI Inc. - Product / Service
  • Tempus AI Inc. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations